معرفی
Benjamin Fisher is a Professor in Rheumatology, Inflammation, and Ageing, actively contributing to autoimmune disease research. He collaborates with institutions like the British Sjögren’s Syndrome Association, Cancer Research UK, and the NIHR through principal and co-investigator roles in projects such as:
- Novartis MTA (2024–2025): Exploring Sjögren’s proteomic signatures
- RANKL Therapeutic Target (2024–2025): Validating drug targets in Sjögren’s
- CRUK Core Funding (2023–2028): Supporting cancer-related research
- REACT Trial (2023–2028): Managing CPI-induced arthritis
۰مقاله منتشرشده
